Skip to main content

$0.042 0.001 (2.44%)

High

$0.04

Low

$0.04

Trades

9

Turnover

$6,168

Volume

149,220
30 June 2023 at 4:10pm
Register to track RHT and receive email alerts.
Subject
RHT Ann: Annual Report to shareholders

RHT Ann: Change in substantial holding

RHT Ann: R&D Molecular Medicine ASON Project Results of Dosing Study

RHT Ann: Preliminary Final Report

RHT Ann: Quarterly Activities/Appendix 4C Cash Flow Report

RHT Ann: Appointment of GM - Global Sales & Marketing

RHT Ann: Change of Director's Interest Notice

RHT Ann: Cancellation of Unlisted Options

RHT Ann: Controlled Placement Facility - Extension and Increase

RHT Ann: Change of Director's Interest Notice

RHT Ann: Appointment of Managing Director

RHT Ann: Secondary Trading Notice

RHT Ann: Application for quotation of securities - RHT

RHT Ann: Resignation of CEO & Management Changes

RHT Ann: Filing of Patent Application

RHT Ann: R&D Update - Molecular Medicine ASO Project

RHT Ann: Appendix 4C - quarterly

RHT Ann: Appointment of CFO & Company Secretary

RHT Ann: Change of Director's Interest Notice

RHT Ann: Secondary Trading Notice & Appendix 2A

RHT Ann: Half Yearly Report and Accounts

RHT Ann: HepaFat-AI receives CE Marking

RHT Ann: HepaFat-AI Receives TGA Approval

RHT Ann: Trading Halt

RHT Ann: Pause in Trading

RHT Ann: Appendix 4C - quarterly

RHT Ann: Secondary Trading Notice & Appendix 2A

RHT Ann: Secondary Trading Notice & Appendix 2A

RHT Ann: Secondary Trading Notice & Appendix 2A

RHT Ann: HepaFat-AI Incorporated into Blackford Analysis

RHT Ann: Secondary Trading Notice & Appendix 2A

RHT Ann: HepaFat-AI gains US FDA clearance

RHT Ann: Trading Halt

RHT Ann: Pause in Trading

RHT Ann: Secondary Trading Notice & Appendix 2A

RHT Ann: Results of Meeting

RHT Ann: Investor Presentation November 2020

RHT Ann: Appendix 4C - quarterly

RHT Ann: Notice of Annual General Meeting/Proxy Form

Register to track RHT and receive email alerts.

Similar Companies

AT1
COH
CSX
CYC
EMV
IBX
IPD
MX1
RSH
SOM